The policy states that lab tests without FDA's blessing may pursue local coverage via Medicare contractors, but national coverage requires premarket approval or clearance.

The decision, which the company said was made for business and financial reasons, raises questions about the viability of such tests in the face of reimbursement uncertainly.

Including this latest round of financing, Tempus has raised a total of $210 million to date.

The company will use the funding to build a manufacturing facility, expand commercialization efforts, and develop new products.

The suit alleges that Natera's Panorama test infringes US Patent No. 9,493,831 patent, which covers sequencing library preparation methods applied to maternal blood samples.

Thermo Fisher said that IntegenX complements and enhances its existing human identification product portfolio.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.

Sponsored by

Machine learning is a field of computer science that gives computers the ability to learn without being explicitly programmed. This webinar explores the basics of machine learning, focusing on the industry standard CRISP-DM (Cross Industry Standard Process for Data Mining), and how to apply the method to a molecular diagnostic technique such as PCR. The webinar also discusses the implications of current PCR analysis software and the lack of artificial intelligence. Lastly - a novel and improved way of analyzing PCR results is introduced.

This application note demonstrates that:

• The new Applied Biosystems SeqStudio Genetic Analyzer generates high-quality data from multiplex ligation–dependent probe amplification (MLPA) assays developed by MRC-Holland.

• The SeqStudio Genetic Analyzer provides fast and efficient results; each run cycle accommodates 4 MLPA reaction samples and can be completed within 45 min.